cognitive cybersecurity intelligence

News and Analysis

Search

Illumina Shares Steady as Icahn Escalates Proxy Fight

Illumina CEO Francis deSouza
The price of Illumina (ILMN) stock has hardly budged this past week, but that calm belies a continuing storm of developments that included a regulatory setback for the sequencing giant and escalating criticism from activist investor Carl Icahn—who…

Source: www.genengnews.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts